Important Facts About Danaher Stock

Shares of Industrials sector company Danaher moved 0.6% today, and are now trading at a price of $255.31. The large-cap stock's daily volume was 1,124,717 compared to its average volume of 2,735,158. The S&P 500 index returned a -0.0% performance.

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company is based in Washington and has 79,000 full time employees. Its market capitalization is $188,508,651,520. Danaher currently offers its equity investors a dividend that yields 0.4% per year.

19 analysts are following Danaher and have set target prices ranging from $230.0 to $325.0 per share. On average, they have given the company a rating of buy. At today's prices, DHR is trading -9.03% away from its average analyst target price of $280.65 per share.

Over the last year, DHR shares have gone down by -7.0%, which represents a difference of -23.0% when compared to the S&P 500. The stock's 52 week high is $283.63 per share and its 52 week low is $221.22.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2023-02-22 8,519,000 -1,143,000 9,662,000 0.51
2022-02-23 8,358,000 -1,255,000 9,613,000 55.78
2021-02-25 6,208,000 37,000 6,171,000 34.89
2020-02-21 3,952,000 -623,000 4,575,000 -0.54
2019-02-21 4,022,000 -578,000 4,600,000 13.17
2018-02-21 3,477,800 -587,000 4,064,800
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.